Review Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: In combination with chemotherapy, for the remedy of adult individuals with regionally recurrent unresectable or metastatic triple-damaging breast cancer who may have not been given prior chemotherapy for metastatic condition and whose tumours Specific programmed cell death-ligand one (put together positiv... https://jamesk012sdw6.wikihearsay.com/user